Cargando…
An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker
BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN)...
Autores principales: | , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793347/ https://www.ncbi.nlm.nih.gov/pubmed/29385987 http://dx.doi.org/10.1186/s12885-018-4006-5 |
_version_ | 1783296931366174720 |
---|---|
author | Goto, Takuma Fujiya, Mikihiro Konishi, Hiroaki Sasajima, Junpei Fujibayashi, Shugo Hayashi, Akihiro Utsumi, Tatsuya Sato, Hiroki Iwama, Takuya Ijiri, Masami Sakatani, Aki Tanaka, Kazuyuki Nomura, Yoshiki Ueno, Nobuhiro Kashima, Shin Moriichi, Kentaro Mizukami, Yusuke Kohgo, Yutaka Okumura, Toshikatsu |
author_facet | Goto, Takuma Fujiya, Mikihiro Konishi, Hiroaki Sasajima, Junpei Fujibayashi, Shugo Hayashi, Akihiro Utsumi, Tatsuya Sato, Hiroki Iwama, Takuya Ijiri, Masami Sakatani, Aki Tanaka, Kazuyuki Nomura, Yoshiki Ueno, Nobuhiro Kashima, Shin Moriichi, Kentaro Mizukami, Yusuke Kohgo, Yutaka Okumura, Toshikatsu |
author_sort | Goto, Takuma |
collection | PubMed |
description | BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN) diagnosis remains unclear. We herein evaluated the usefulness of miRs enclosed in serum exosomes (ExmiRs) as diagnostic markers. METHODS: The ExmiRs from patients with pancreatic cancer (n = 32) or IPMN (n = 29), and patients without neoplasms (controls; n = 22) were enriched using ExoQuick-TC™. The expression of ExmiRs was evaluated using a next-generation sequencing analysis, and the selected three miRs through this analysis were confirmed by a quantitative real-time polymerase chain reaction. RESULTS: The expression of ExmiR-191, ExmiR-21 and ExmiR-451a was significantly up-regulated in patients with pancreatic cancer and IPMN compared to the controls (p < 0.05). A receiver operating characteristic curve analysis showed that the area under the curve and the diagnostic accuracy of ExmiRs were 5–20% superior to those of three serum bulky circulating miRs (e.g.; ExmiR-21: AUC 0.826, accuracy 80.8%. Circulating miR-21: AUC 0.653, accuracy 62.3%). In addition, high ExmiR-451a was associated with mural nodules in IPMN (p = 0.010), and high ExmiR-21 was identified as a candidate prognostic factor for the overall survival (p = 0.011, HR 4.071, median OS of high-ExmiR-21: 344 days, median OS of low-ExmiR-21: 846 days) and chemo-resistant markers (p = 0.022). CONCLUSIONS: The level of three ExmiRs can thus serve as early diagnostic and progression markers of pancreatic cancer and IPMN, and considered more useful markers than the circulating miRs (limited to these three miRs). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4006-5) contains supplementary material, which is available to authorized users. |
format | Online Article Text |
id | pubmed-5793347 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-57933472018-02-12 An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker Goto, Takuma Fujiya, Mikihiro Konishi, Hiroaki Sasajima, Junpei Fujibayashi, Shugo Hayashi, Akihiro Utsumi, Tatsuya Sato, Hiroki Iwama, Takuya Ijiri, Masami Sakatani, Aki Tanaka, Kazuyuki Nomura, Yoshiki Ueno, Nobuhiro Kashima, Shin Moriichi, Kentaro Mizukami, Yusuke Kohgo, Yutaka Okumura, Toshikatsu BMC Cancer Research Article BACKGROUND: Pancreatic cancer is associated with an extremely poor prognosis, so new biomarkers that can detect the initial stages are urgently needed. The significance of serum microRNA (miR) levels in pancreatic neoplasm such as pancreatic cancer and intraductal papillary mucinous neoplasm (IPMN) diagnosis remains unclear. We herein evaluated the usefulness of miRs enclosed in serum exosomes (ExmiRs) as diagnostic markers. METHODS: The ExmiRs from patients with pancreatic cancer (n = 32) or IPMN (n = 29), and patients without neoplasms (controls; n = 22) were enriched using ExoQuick-TC™. The expression of ExmiRs was evaluated using a next-generation sequencing analysis, and the selected three miRs through this analysis were confirmed by a quantitative real-time polymerase chain reaction. RESULTS: The expression of ExmiR-191, ExmiR-21 and ExmiR-451a was significantly up-regulated in patients with pancreatic cancer and IPMN compared to the controls (p < 0.05). A receiver operating characteristic curve analysis showed that the area under the curve and the diagnostic accuracy of ExmiRs were 5–20% superior to those of three serum bulky circulating miRs (e.g.; ExmiR-21: AUC 0.826, accuracy 80.8%. Circulating miR-21: AUC 0.653, accuracy 62.3%). In addition, high ExmiR-451a was associated with mural nodules in IPMN (p = 0.010), and high ExmiR-21 was identified as a candidate prognostic factor for the overall survival (p = 0.011, HR 4.071, median OS of high-ExmiR-21: 344 days, median OS of low-ExmiR-21: 846 days) and chemo-resistant markers (p = 0.022). CONCLUSIONS: The level of three ExmiRs can thus serve as early diagnostic and progression markers of pancreatic cancer and IPMN, and considered more useful markers than the circulating miRs (limited to these three miRs). ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12885-018-4006-5) contains supplementary material, which is available to authorized users. BioMed Central 2018-01-31 /pmc/articles/PMC5793347/ /pubmed/29385987 http://dx.doi.org/10.1186/s12885-018-4006-5 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Research Article Goto, Takuma Fujiya, Mikihiro Konishi, Hiroaki Sasajima, Junpei Fujibayashi, Shugo Hayashi, Akihiro Utsumi, Tatsuya Sato, Hiroki Iwama, Takuya Ijiri, Masami Sakatani, Aki Tanaka, Kazuyuki Nomura, Yoshiki Ueno, Nobuhiro Kashima, Shin Moriichi, Kentaro Mizukami, Yusuke Kohgo, Yutaka Okumura, Toshikatsu An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title | An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title_full | An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title_fullStr | An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title_full_unstemmed | An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title_short | An elevated expression of serum exosomal microRNA-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
title_sort | elevated expression of serum exosomal microrna-191, − 21, −451a of pancreatic neoplasm is considered to be efficient diagnostic marker |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5793347/ https://www.ncbi.nlm.nih.gov/pubmed/29385987 http://dx.doi.org/10.1186/s12885-018-4006-5 |
work_keys_str_mv | AT gototakuma anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT fujiyamikihiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT konishihiroaki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT sasajimajunpei anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT fujibayashishugo anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT hayashiakihiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT utsumitatsuya anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT satohiroki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT iwamatakuya anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT ijirimasami anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT sakataniaki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT tanakakazuyuki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT nomurayoshiki anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT uenonobuhiro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT kashimashin anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT moriichikentaro anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT mizukamiyusuke anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT kohgoyutaka anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT okumuratoshikatsu anelevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT gototakuma elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT fujiyamikihiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT konishihiroaki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT sasajimajunpei elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT fujibayashishugo elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT hayashiakihiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT utsumitatsuya elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT satohiroki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT iwamatakuya elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT ijirimasami elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT sakataniaki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT tanakakazuyuki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT nomurayoshiki elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT uenonobuhiro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT kashimashin elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT moriichikentaro elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT mizukamiyusuke elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT kohgoyutaka elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker AT okumuratoshikatsu elevatedexpressionofserumexosomalmicrorna19121451aofpancreaticneoplasmisconsideredtobeefficientdiagnosticmarker |